Literature DB >> 19414225

Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Silvia S Martins1, Katherine M Keyes, Carla L Storr, Hong Zhu, Howard D Chilcoat.   

Abstract

BACKGROUND: While nonmedical use of opioids and psychiatric disorders are prevalent in the population, little is known about the temporal ordering between nonmedical opioid use and dependence and psychiatric disorders.
METHOD: Data were gathered in a face-to-face survey of the United States conducted in the 2001-2002 (NESARC wave 1). Participants were household and group quarters residents aged 18 years and older (n=43,093). Cox proportional hazards models with time-dependent covariates were used to investigate potential pathways between lifetime nonmedical opioid use/dependence and psychiatric disorders.
RESULTS: Preexisting psychiatric disorders (mood disorders, major depressive disorder, bipolar I disorder, anxiety disorders, panic and generalized anxiety disorders) were associated with an increased risk of nonmedical opioid use, with hazard ratios ranging from 2.2[95% CI=1.6-3.1] (any anxiety disorder) to 3.1[95% CI=2.4-2.4] (bipolar I disorder). Preexisting nonmedical opioid use was associated with an increased risk of onset of psychiatric disorders, with hazard ratios ranging from 2.8[95% CI=2.2-3.6] (generalized anxiety disorder) to 3.6[95% CI=2.6-4.9] (bipolar I disorder), adjusted for demographics and other illegal drug use. Nonmedical use of opioids led to the development of dependence more often among individuals with preexisting psychiatric disorders, hazard ratios were particularly strong for generalized anxiety disorder (HR=10.8, 95% CI=4.9-23.7) and bipolar I disorder (HR=9.7, 95% CI=5.4-17.3). Preexisting opioid dependence resulting from nonmedical opioid use was associated with an increased risk of onset of psychiatric disorders, with hazard ratios ranging from 4.9[95% CI=3.0-7.9] (mood disorders) to 8.5[95% CI=4.5-16.0] (panic disorder), adjusted for demographics and alcohol and/or other illegal drug dependence.
CONCLUSIONS: Our findings support a general vulnerability to nonmedical opioid use and major psychopathologies, as well as evidence for a 'self-medication' model for dependence resulting from nonmedical opioid use with bipolar disorder and generalized anxiety disorder.

Entities:  

Mesh:

Year:  2009        PMID: 19414225      PMCID: PMC2699563          DOI: 10.1016/j.drugalcdep.2009.01.019

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  53 in total

1.  Genetic and environmental influences on behavioral disinhibition.

Authors:  S E Young; M C Stallings; R P Corley; K S Krauter; J K Hewitt
Journal:  Am J Med Genet       Date:  2000-10-09

2.  Mania and tramadol-fluoxetine combination.

Authors:  A Gonzalez-Pinto; H Imaz; J L De Heredia; M Gutierrez; J A Micó
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

3.  Association of a polymorphism of the dopamine transporter gene with externalizing behavior problems and associated temperament traits: a longitudinal study from infancy to the mid-teens.

Authors:  A F Jorm; M Prior; A Sanson; D Smart; Y Zhang; S Easteal
Journal:  Am J Med Genet       Date:  2001-05-08

4.  Psychiatric disorders associated with substance use among children and adolescents: findings from the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study.

Authors:  D B Kandel; J G Johnson; H R Bird; G Canino; S H Goodman; B B Lahey; D A Regier; M Schwab-Stone
Journal:  J Abnorm Child Psychol       Date:  1997-04

5.  Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma.

Authors:  Naomi Breslau; Glenn C Davis; Lonni R Schultz
Journal:  Arch Gen Psychiatry       Date:  2003-03

6.  Use of opioid medications for chronic noncancer pain syndromes in primary care.

Authors:  M Carrington Reid; Laura L Engles-Horton; MaryAnn B Weber; Robert D Kerns; Elizabeth L Rogers; Patrick G O'Connor
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

7.  The structure and stability of common mental disorders: the NEMESIS study.

Authors:  W A Vollebergh; J Iedema; R V Bijl; R de Graaf; F Smit; J Ormel
Journal:  Arch Gen Psychiatry       Date:  2001-06

8.  Dopamine transporter polymorphism associated with externalizing behavior problems in children.

Authors:  Susan E Young; Andrew Smolen; Robin P Corley; Kenneth S Krauter; John C DeFries; Thomas J Crowley; John K Hewitt
Journal:  Am J Med Genet       Date:  2002-03-08

9.  The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population.

Authors:  G Canino; M Bravo; R Ramírez; V E Febo; M Rubio-Stipec; R L Fernández; D Hasin
Journal:  J Stud Alcohol       Date:  1999-11

10.  Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities.

Authors:  Andrew Rosenblum; Herman Joseph; Chunki Fong; Steven Kipnis; Charles Cleland; Russell K Portenoy
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  61 in total

1.  Birth-cohort trends in lifetime and past-year prescription opioid-use disorder resulting from nonmedical use: results from two national surveys.

Authors:  Silvia S Martins; Katherine M Keyes; Carla L Storr; Hong Zhu; Richard A Grucza
Journal:  J Stud Alcohol Drugs       Date:  2010-07       Impact factor: 2.582

2.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

3.  Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States.

Authors:  Katherine M Keyes; Magdalena Cerdá; Joanne E Brady; Jennifer R Havens; Sandro Galea
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

4.  Clinical correlates of prescription opioid analgesic use in pregnancy.

Authors:  Megan V Smith; Darce Costello; Kimberly A Yonkers
Journal:  Matern Child Health J       Date:  2015-03

5.  Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.

Authors:  Merav Kovatch; Daniel Feingold; Odelia Elkana; Shaul Lev-Ran
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-23       Impact factor: 4.035

6.  Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain.

Authors:  Laura P Richardson; Joan E Russo; Wayne Katon; Carolyn A McCarty; Andrea DeVries; Mark J Edlund; Bradley C Martin; Mark Sullivan
Journal:  J Adolesc Health       Date:  2012-02-28       Impact factor: 5.012

7.  Gender and prescription opioids: findings from the National Survey on Drug Use and Health.

Authors:  Sudie E Back; Rebecca L Payne; Annie N Simpson; Kathleen T Brady
Journal:  Addict Behav       Date:  2010-06-22       Impact factor: 3.913

8.  Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic.

Authors:  Gillian A Beauchamp; Erin L Winstanley; Shawn A Ryan; Michael S Lyons
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

Review 9.  Management of opioid medications in patients with chronic pain and risk of substance misuse.

Authors:  Seddon R Savage
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

10.  Self-loathing aspects of depression reduce postoperative opioid cessation rate.

Authors:  Jennifer M Hah; Sean Mackey; Peter L Barelka; Charlie K M Wang; Bing M Wang; Matthew J Gillespie; Rebecca McCue; Jarred W Younger; Jodie Trafton; Keith Humphreys; Stuart B Goodman; Fredrick M Dirbas; Peter C Schmidt; Ian R Carroll
Journal:  Pain Med       Date:  2014-06       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.